Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,662 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,108
Recruiting: 10,888
Ph III recruiting: 1,278
Growth YoY: +12.8%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,158)

clinicaltrialsPublishedShowing 2,501–2,527 of 2,527 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03061539	Nivolumab and Ipilimumab Treatment in Prostate Cancer With an Immunogenic Signature	active not recruiting	Phase 2	380	University College, LondonOTHER	1	Sep 28, 2022	clinicaltrials
NCT02415413	Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma	active not recruiting	Phase 2	90	PETHEMA FoundationOTHER	1	Sep 10, 2022	clinicaltrials